Metabolic Pathway Research
Tirzepatide
Tirzepatide is a synthetic peptide and dual GIP / GLP-1 receptor agonist. It is studied within receptor signalling and metabolic pathway research.
Identity
Terms used here are defined in the glossary.
Batches tested
Every batch is analysed by an independent laboratory before release. Results below describe the batch named, and do not carry across to any other batch.
5 August 2026 · Ozcanium Analytics
95.52% purity
28.55mg net content
5 August 2026 · Ozcanium Analytics
95.35% purity
9.51mg net content
How to verify what you have
Read the batch number from the vial label, find that batch above or in the COA Library, and open its certificate. The report code on the certificate can be checked directly with the testing laboratory, so verification does not depend on us.
The methods behind those figures are set out in Testing Standards.
Supply
Supplied as lyophilised powder, Express Post Australia-wide from Melbourne. See Tirzepatide for sizes and current pricing, and Supply Conditions for the terms of supply.
This page states identity, specifications and test results only. No guidance is given on use, preparation or quantities. For research purposes only. Not for human consumption, therapeutic use, veterinary use, diagnostic use, or clinical application.